Inventaire - your friends and communities are your best library

PPAR Regulation of Inflammatory Signaling in CNS Diseases

published in: PPAR Research

date of publication: 2008-01-01

main subject: inflammation

Cites articles 107

Date

Title

Authors

2007-11-22

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

Dario Vignali, Kelli L. Boyd
2007-07-01

Immunopathogenesis of central nervous system fungal infections

Emmanuel Roilides
2007-09-01

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

A Michael Lincoff, Steven Nissen
2007-02-27

The PPAR gamma agonist Pioglitazone improves anatomical and locomotor recovery after rodent spinal cord injury

Richa Tripathi
2007-04-09

PPAR-gamma: therapeutic target for ischemic stroke
2007-04-01

Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents
2007-03-01

The JAK-STAT signaling pathway: input and output integration
2007-03-01

Chemokines and chemokine receptors in multiple sclerosis. Potential targets for new therapies
2007-01-01

The Effect of PPARalpha, PPARdelta, PPARgamma, and PPARpan Agonists on Body Weight, Body Mass, and Serum Lipid Profiles in Diet-Induced Obese AKR/J Mice
2007-11-01

Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease

Beate Ritz
2007-09-20

Pioglitazone exerts protective effects against stroke in stroke-prone spontaneously hypertensive rats, independently of blood pressure

Hisao Ogawa
2007-07-11

Gemfibrozil ameliorates relapsing-remitting experimental autoimmune encephalomyelitis independent of peroxisome proliferator-activated receptor-alpha.
2007-03-15

Cell surface adhesion molecules and cytokine profiles in primary progressive multiple sclerosis.

Birgit Reipert
2007-05-01

MRI monitoring of focal cerebral ischemia in peroxisome proliferator-activated receptor (PPAR)-deficient mice

Béatrice Desvergne, Jean-Baptiste Pialat, Marc Janier, Marlene Wiart
2007-01-01

Peroxisome proliferator-activated receptor-gamma Pro12Ala polymorphism is associated with the susceptibility to ischemic stroke in Taeeumin classified by Sasang medicine
2007-04-01

Peroxisome proliferator-activated receptor gamma (PPARgamma) and immunoregulation: enhancement of regulatory T cells through PPARgamma-dependent and -independent mechanisms

Erin Nevius
2007-02-01

T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity
2006-12-13

Neuroprotective efficacy of the peroxisome proliferator-activated receptor delta-selective agonists in vitro and in vivo
2006-08-18

An internally controlled peripheral biomarker for Alzheimer's disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin
2006-06-14

Antigen presentation in autoimmunity and CNS inflammation: how T lymphocytes recognize the brain

Burkhard Becher, Melanie Greter
2006-03-01

Pathophysiology of interleukin-23 in experimental autoimmune encephalomyelitis

Bruno Gran
2006-02

TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells

Brigitta Stockinger, Marc Veldhoen
2006-11-01

Rosiglitazone, a peroxisome proliferator-activated receptor-gamma ligand, reduces infarction volume and neurological deficits in an embolic model of stroke.
2006-05-10

Oxidative stress and inflammatory response evoked by transient cerebral ischemia/reperfusion: effects of the PPAR-alpha agonist WY14643.

Raffaella Mastrocola, Chiara Dianzani, Roberto Fantozzi, Christoph Thiemermann
2006-05-24

Neuronal expression of peroxisome proliferator-activated receptor-gamma (PPARgamma) and 15d-prostaglandin J2--mediated protection of brain after experimental cerebral ischemia in rat.
2006-05-01

1,25 Dihydroxyvitamin-D3 modulates JAK-STAT pathway in IL-12/IFNgamma axis leading to Th1 response in experimental allergic encephalomyelitis
2006-01-01

Epigenetic modification of SOCS-1 differentially regulates STAT3 activation in response to interleukin-6 receptor and epidermal growth factor receptor signaling through JAK and/or MEK in head and neck squamous cell carcinomas

Tin-Lap Lee
2006-07-17

PPARgamma antagonists reverse the inhibition of neural antigen-specific Th1 response and experimental allergic encephalomyelitis by Ciglitazone and 15-deoxy-Delta12,14-prostaglandin J2
2005-12-01

Clinical aspects of inflammation in Alzheimer's disease
2005-11-01

Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study

Brenna Cholerton, Laura D. Baker, Suzanne Craft
2005-10-01

Dose-dependent neuroprotective effects of melatonin on experimental spinal cord injury in rats
2005-12

Non-steroidal anti-inflammatory drugs have anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro

Article - wd:Q37231755

Welcome to Inventaire

the library of your friends and communities

learn more